KFSH Madinah team delivers baby after decade of recurrent fetal loss

King Faisal Specialist Hospital and Research Centre in Madinah used early intervention, plasma exchange and fetal blood transfusions to help a 34-year-old woman carry a pregnancy to delivery after 10 years of recurrent fetal losses. The case shows how coordinated maternal-fetal and neonatal care can change outcomes in high-risk pregnancies.

Why it matters: - The case shows that earlier intervention can extend a high-risk pregnancy long enough to give doctors more treatment options. - The baby was born after a decade of recurrent fetal losses linked to a severe maternal immune condition. - The outcome highlights the role of specialized maternal-fetal care, fetal transfusion and neonatal support in preventing avoidable complications.

What happened: - King Faisal Specialist Hospital and Research Centre in Madinah treated a 34-year-old woman with recurrent fetal losses over 10 years. - The pregnancy was complicated by maternal Anti-Kell antibodies, which can cross the placenta and affect fetal red blood cells. - The care team used early therapeutic intervention to limit the antibody impact on the fetus. - The pregnancy ended with an emergency cesarean section after changes in the fetal heartbeat. - The delivery resulted in a baby boy weighing about 1.65 kilograms.

The details: - A multidisciplinary team started treatment with plasma exchange to lower antibody levels in the mother’s blood. - The team then used medication and weekly fetal monitoring. - The approach prevented the abnormal fluid buildup seen in previous pregnancies. - Severe fetal anemia was delayed until the 28th week of pregnancy. - The team completed two intrauterine blood transfusions for the fetus. - The transfusions were done in collaboration with colleagues at King Faisal Specialist Hospital and Research Centre in Riyadh. - After birth, the baby received phototherapy and transfusions of blood and blood products based on his clinical condition. - The baby was discharged home and continues regular follow-up care. - The child is currently meeting expected growth and developmental milestones, with no reported complications. - Dr. Osama Alharbi, Consultant, Maternal Fetal Medicine at KFSH, said reaching a more advanced stage of pregnancy gave the team more options to treat the fetus inside the womb or deliver when needed.

Between the lines: - The case suggests that severe immune-related fetal complications are not always irreversible when identified and managed early. - Delaying deterioration until later in pregnancy can improve the odds of both fetal survival and neonatal stability. - The hospital is also using this case to underscore its broader medical standing. - KFSH ranked first in the Middle East and Africa and 12th globally among the world’s top 250 academic medical centers for 2026. - Brand Finance named KFSH the most valuable healthcare brand in Saudi Arabia and the Middle East for 2026. - Newsweek included KFSH in its 2026 lists of the World’s Best Hospitals, World’s Best Smart Hospitals and World’s Best Specialized Hospitals.

What's next: - The baby will continue regular follow-up care to track growth and development. - The case may reinforce use of early antibody-lowering treatment and close fetal surveillance in similar high-risk pregnancies.

The bottom line: - Early, coordinated intervention helped turn years of recurrent pregnancy loss into a live birth.